-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Depreciation history and growth rate from 2022 to 2024.
- Dianthus Therapeutics, Inc. /DE/ Depreciation for the quarter ending March 31, 2024 was $22 K, a 57.1% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ annual Depreciation for 2023 was $67 K, a 123% increase from 2022.
- Dianthus Therapeutics, Inc. /DE/ annual Depreciation for 2022 was $30 K.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)